Treatment For Triple Negative Breast Cancer. The treatment could be critical in overcoming multidrug resistance that limits therapy options for triple negative breast cancer. Researchers at the university of toledo have received a three year funding award of 1 4 million from the u s.
Pin On Hospitals Healthcare Check Your Health Meter from www.pinterest.com
Chemotherapy has been the mainstay of treatment for triple negative breast cancer. Hormone therapy and drugs that target her2 are not helpful so chemotherapy is the main systemic treatment option. Department of defense for a pre clinical study of promising new chemotherapy aimed at triple negative breast cancer.
Treatment of triple negative breast cancer.
Because the cancer cells lack these proteins treatment options for triple negative breast cancer are limited. Metastatic triple negative breast cancer is an aggressive form of breast cancer with limited treatment options. The drug approved last year is tecentriq atezolizumab and is given in combination with chemotherapy for patients with metastatic tnbc and tumors expressing the biomarker pd l1. Chemotherapy has been the mainstay of treatment for triple negative breast cancer.
